Get the Stockscreener App
21.41
12.39%
2.36
Pre-market:
21.87
0.46
+2.15%
Overview
News
Price History
Option Chain
Why RGS Down?
Discussions
Forecast
Stock Split
Dividend History
Regis Corp. stock is traded at $21.41, with a volume of 90,294.
It is up +12.39% in the last 24 hours and down -16.17% over the past month.
Regis Corporation owns, operates, and franchises hairstyling and hair care salons. The company operates through two operating segments, Company-owned salons and Franchise salons. Its salons operate primarily under the trade names of SmartStyle, Supercuts, MasterCuts, Regis Salons, and Cost Cutters; and serve value and premium categories of services. The company's SmartStyle, Signature Style, MasterCuts, Regis, and International salon concepts offer a range of custom styling, cutting, and hair coloring, as well as professional hair care products; and Supercuts salon concepts provide high quality hair care services and professional hair care products. As of June 30, 2018, the Company-owned salon segment operated 3,966 company-owned salons in the United States, Canada, and Puerto Rico; and the Franchise salon segment operated 4,114 franchised salons in the United States, Canada, the United Kingdom, and Puerto Rico. The company, through its 54.6% interest in Empire Education Group, Inc., operates accredited cosmetology schools. Regis Corporation was founded in 1954 and is headquartered in Edina, Minnesota.
See More
Previous Close:
$19.05
Open:
$19.01
24h Volume:
90,294
Relative Volume:
1.37
Market Cap:
$43.55M
Revenue:
$195.67M
Net Income/Loss:
$89.01M
P/E Ratio:
-133.81
EPS:
-0.16
Net Cash Flow:
$-789.00K
1W Performance:
+18.94%
1M Performance:
-16.17%
6M Performance:
+303.20%
1Y Performance:
+6,001%
1-Day Range:
$19.00
$21.99
1-Week Range:
$17.00
$21.99
52-Week Range:
$0.3133
$35.50
Regis Corp. Stock (RGS) Company Profile
Name
Regis Corp.
Sector
Industry
Phone
952-947-7777
Address
7201 Metro Boulevard, Edina, MN
Compare RGS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| RGS | 21.41 | 43.55M | 195.67M | 89.01M | -789.00K | -0.16 |
| ROL | 49.63 | 24.04B | 3.31B | 469.51M | 537.75M | 0.83 |
| SCI | 86.13 | 12.43B | 4.15B | 505.69M | 587.50M | 3.18 |
| HRB | 56.87 | 7.94B | 3.61B | 595.32M | 657.18M | 3.57 |
| BFAM | 111.05 | 6.46B | 2.63B | 116.59M | 216.16M | 1.49 |
| FTDR | 57.44 | 4.36B | 1.83B | 234.00M | 235.00M | 2.11 |
Regis Corp. Stock (RGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-01-21 | Upgrade | Loop Capital | Hold → Buy |
| Jan-22-21 | Downgrade | Jefferies | Buy → Hold |
| Oct-22-20 | Downgrade | Loop Capital | Buy → Hold |
| Apr-05-19 | Initiated | Loop Capital | Buy |
| Dec-21-17 | Initiated | KeyBanc Capital Mkts | Sector Weight |
| Sep-13-17 | Initiated | Jefferies | Buy |
| May-19-16 | Downgrade | Piper Jaffray | Neutral → Underweight |
| Nov-19-15 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Oct-30-15 | Upgrade | Northcoast | Sell → Neutral |
| Aug-31-15 | Downgrade | Northcoast | Buy → Neutral |
| Mar-01-11 | Initiated | Oppenheimer | Outperform |
| Dec-21-10 | Upgrade | Wedbush | Neutral → Outperform |
| Oct-29-10 | Reiterated | Feltl & Co. | Hold |
| Oct-29-10 | Reiterated | Wedbush | Neutral |
| Jul-09-10 | Downgrade | Feltl & Co. | Buy → Hold |
| Jan-12-10 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-04-09 | Initiated | Wedbush Morgan | Neutral |
| Aug-21-09 | Reiterated | Credit Suisse | Outperform |
| Aug-21-09 | Upgrade | Feltl & Co. | Hold → Buy |
| Aug-13-09 | Initiated | Feltl & Co. | Hold |
| Jul-31-09 | Initiated | Credit Suisse | Outperform |
View All
Regis Corp. Stock (RGS) Latest News
Regis Corporation (NYSE:RGS) Q1 2025 Earnings Call Transcript - Insider Monkey
Regis Corp (RGS) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Initiatives By GuruFocus - Investing.com Canada
Regis: Fiscal Q1 Earnings Snapshot - Houston Chronicle
Regis Corporation Reports Continued Profitability for the First Fiscal Quarter 2025 - Yahoo Finance
Regis Corp Reports Q1 2025 Earnings: Adjusted EPS at $0.93, Reve - GuruFocus.com
Regis to Issue First Quarter Fiscal 2025 Results on November 6, 2024 - StockTitan
Supercuts® Debuts Nationwide Loyalty Program with Guests Able to Earn Free Haircuts and More - Quantisnow
Lapses in autopsy report: RG Kar doctor at CBI office for interrogation - Lokmat Times
RG Kar case: CBI finds more procedural lapses in autopsy report - Lokmat Times
Keros Therapeutics Inc [KROS] Insider GORDON CARL L sells 250,000 Shares for $250,000 - Knox Daily
Chief Executive Officer, Scots-Knight Denise sold 60,046 shares of Mereo Biopharma Group Plc ADR [MREO] - Knox Daily
Regeneron slump continues as analysts turn more cautious - MSN
Keros Therapeutics Inc (KROS)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
GRI’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
Closing Strong: Mereo Biopharma Group Plc ADR (MREO) Ends at 4.09, Down -3.76 from Last Close - The Dwinnex
GEELY AUTO Partners with Tasco to Set Up Auto Assembly Plant in Vietnam w/ Total Investment Amt ~US$168M - AASTOCKS.com
Cong asks Guv to intervene in “illegally IPB permitted” mega projects in Reis Magos - Herald Goa
Keros Therapeutics (NASDAQ:KROS) Shares Gap Up to $55.80 - MarketBeat
How the (KROS) price action is used to our Advantage - Stock Traders Daily
How does Keros Therapeutics Inc (KROS) change from a tortoise to a hare? - SETE News
Keros Therapeutics (NASDAQ:KROS) Receives New Coverage from Analysts at Guggenheim - MarketBeat
Guggenheim starts Keros Therapeutics with 'buy' on lung disorder drug potential - XM
Guggenheim bullish on Keros Therapeutics stock driven by PAH treatment prospects - Investing.com Australia
Regis drops $103.5m on aged care villages - realestatesource.com.au
Public Employees Retirement Association of Colorado Sells 674 Shares of Targa Resources Corp. (NYSE:TRGP) - Defense World
Latest News LIVE Updates: RG Kar junior doctors withdraw 42-day `cease work` - mid-day.com
Mereo BioPharma Group (NASDAQ:MREO) Shares Gap Up to $3.95 - Defense World
RG Kar scam: CBI gets clues of Sandip Ghosh illegally awarding contracts to biz entity - Punjab News Express
Regis Healthcare (ASX:REG) share price jumps on acquisition, aged care reforms - Rask Media
Australia's Regis Healthcare hits over 8-yr high as co plans to acquire residential homes - XM
Up 124% in a year, ASX 300 healthcare share lifts off on $35 million acquisition - MSN
Edgestream Partners L.P. Makes New Investment in Herc Holdings Inc. (NYSE:HRI) - Defense World
Mereo BioPharma Group plc (NASDAQ:MREO) Insider Sells $23,297.64 in Stock - Defense World
Odisha: Government introduces new safety policy for medical professionals Post RG Kar rape incident - Organiser
R G Kar case: ED summons TMC MLA Sudipto Roy for questioning - NewsDrum
ED seizes documents from TMC MLA’s home in RG Kar Hospital bungling case - Medical Buyer
RG Kar case: CPI(M) youth leader Minakshi Mukherjee appears before CBI - The Economic Times
Mereo BioPharmaLazarus-Like Recovery Impresses, But Lack Of Clarity On Potential Approval Timelines - Seeking Alpha
After RG Kar Episode In Kolkata, Odisha Govt Issues Guidelines For Doctors’ Safety - OdishaBytes
Mereo Biopharma Group Plc ADR (MREO) stock: A year of ups and downs - US Post News
Mereo Biopharma Group Plc ADR (MREO) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle
Mereo BioPharma Group plc (MREO): A Bull Case Theory - Insider Monkey
'Next decade is likely to be a golden era' for ASX shares in this sector - The Motley Fool Australia
BMO holds stock target, outperform rating on Regeneron shares - Investing.com India
Mereo BioPharma Group plc (NASDAQ:MREO) CEO Denise Scots-Knight Sells 28,611 Shares - Defense World
Mereo BioPharma Group plc (NASDAQ:MREO) CFO Christine Ann Fox Sells 9,128 Shares of Stock - Defense World
Mereo BioPharma CFO sells over $121k in company stock - Investing.com
Mereo BioPharma's chief scientific officer sells shares worth over $69,000 - Investing.com India
Mereo BioPharma CFO sells over $120k in company stock - Investing.com India
Mereo BioPharma's general counsel sells over $133k in company stock - Investing.com UK
Views of Wall Street’s Leading Experts on Mereo Biopharma Group Plc ADR - SETE News
Regis Corp. Stock (RGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):